비뇨기암에서 림프절 절제술과 림프부종
Received: Apr 15, 2019; Accepted: May 03, 2019
Published Online: May 31, 2019
Abatract
Lymphedema is uncommon in patients with urologic cancer, but can be associated with gross physical deformity, which severely influences patient‘s health-related quality of life. Lymphedema in patients with urologic cancer is caused by damage or obstruction of the lymphatics due to tumor involvement of the lymph nodes, surgery, radiation, or infection. Lymph node dissection is a common procedure in general surgical urology practice. Evidence has accumulated that lymph node dissection plays a role in the treatment of various urologic cancers. Particularly, lymph node dissection is considered to be associated with survival benefit in patients with advanced bladder cancer or penile cancer. In urologic oncology practice, lymphedema is a rather neglected subject, which is considered to be non-fatal. Prevention, early diagnosis, and proper treatment efforts should be made to minimize the detrimental effects of lymphedema on the patient’s quality of life.
Metrics
QR Code of this Article:
Related Articles
Photo-physical and -Chemical Effects of Low-level LASER on Lymphedema Treatment
Clin. Lymphology Lymphedema 2025;10(2):31-35.
Practical Exercise Program for Patients with Lymphedema
Clin. Lymphology Lymphedema 2025;10(2):36-42.
Current Challenges and Future Directions in Lymphedema Diagnosis and Staging
Clin. Lymphology Lymphedema 2025;10(2):48-52.
Analysis of Predictive Factors for Arm Lymphedema Following Salvage Radiotherapy for Patients with Recurrent Breast Cancer
Clin. Lymphology Lymphedema 2025;10(2):53-62.
Lymphoscintigraphy in Lymphedema: Procedure and Interpretation Guideline by the Korean Society of Nuclear Medicine and Korean Society of Lymphedema Part II
Clin. Lymphology Lymphedema 2025;10(1):1-13.
